Biopsy template: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
|||
Line 6: | Line 6: | ||
==Introduction to the Biopsy Page== | ==Introduction to the Biopsy Page== | ||
==Overview== | ==Overview== | ||
===Template=== | ===Template=== | ||
*'''First sentences''' | |||
:Biopsy findings consistent with [malignancy name] include [finding1], [finding2], [finding3]. | |||
:OR | |||
:There are no biopsy findings consistent with [malignancy name]. | |||
:OR | |||
:On biopsy, [malignancy name] is characterized by [biopsy finding 1], [biopsy finding 2], [biopsy finding 3]. | |||
*'''Examples''' | |||
:Example 1: Biopsy findings consistent with Hodgkin's Lymphoma include Reed-Sternberg cells and complete or partial effacement of the lymph node architecture. | |||
:Example 2: There are no biopsy findings consistent with acinic cell carcinoma. | |||
:Example 3: On biopsy, follicular lymphoma is characterized by centroblasts and centrocytes. | |||
==Key Biopsy Findings in (Disease Name)== | ==Key Biopsy Findings in (Disease Name)== | ||
==Biopsy Exames of (Disease Name)== | ==Biopsy Exames of (Disease Name)== |
Revision as of 20:41, 20 August 2015
To go to the main page, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.
Introduction to the Biopsy Page
Overview
Template
- First sentences
- Biopsy findings consistent with [malignancy name] include [finding1], [finding2], [finding3].
- OR
- There are no biopsy findings consistent with [malignancy name].
- OR
- On biopsy, [malignancy name] is characterized by [biopsy finding 1], [biopsy finding 2], [biopsy finding 3].
- Examples
- Example 1: Biopsy findings consistent with Hodgkin's Lymphoma include Reed-Sternberg cells and complete or partial effacement of the lymph node architecture.
- Example 2: There are no biopsy findings consistent with acinic cell carcinoma.
- Example 3: On biopsy, follicular lymphoma is characterized by centroblasts and centrocytes.